Bristol-Myers Squibb (BMY)
$50.57 0.50 (1.00%)
19:58 EDT BMY Stock Quote Delayed 15 Minutes
Previous Close $50.57
Market Cap 82.66B
PE Ratio 88.72
Volume (Avg. Vol.) 13.58M
Day's Range 49.99 - 50.86
52-Week Range 42.48 - 63.69
Dividend & Yield 1.60 (3.16%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
- From InvestorPlace
- From the Web
The stock charts of EA, AAP and MGM have run through the technical trading wringer in front of today's action.
Bristol-Myers Squibb, Celgene, Caesars Entertainment, Match Group and New Relic are our top stock trades for Tuesday.
Bristol-Meyers Squibb news for Monday has BMY stock taking a beating after announcing a delay to its merger deal with Celgene.
MMM stock has fallen 25% in the past six weeks since announcing weaker-than-expected Q1 earnings. 3M stock has been weak since then.
Buy Pfizer stock on this current round of weakness. The underpinnings are bullish for 2020 and beyond.
Bristol-Myers Squibb earnings for the first quarter of 2019 have BMY stock up Thursday on an earnings per share and revenue beat.
The stock charts of BMY, DISCA and NSC stock merit the closest looks headed into the latter part of the week.
Is Bristol-Myers Squibb stock a buy now? If you're patient enough to wait out the merger jitters, there's a lot to like.
AZN stock is great to own, but you should choose your entry points carefully, as AstraZeneca has some short-term risks ahead.
The stock charts of CTL, CPB and BMY look ready to start the new trading week on the verge of tradeworthy moves. Here are levels to watch.
Celgene and Bristol-Myers got the green light from shareholders to move forward on the deal. More upside awaits for CELG stock.
Restoration Hardware, Bristol-Myers, Celgene, Lyft's IPO and Wells Fargo are our top stock trades to watch for Monday.
Options trading was buzzing in Southwest Airlines, Celgene, and Square on Thursday. Here are the metrics that matter moving forward.
Bristol-Myers deal for Celgene is in doubt, while Box, Square, JD.com and Fitbit are moving on earnings. Here's are top stock trades for Friday.
Celgene stock was on its way down Thursday following news that major investors are against a deal with Bristol-Meyers (BMY).
Options trading was buzzing in Bristol-Myers, Activision Blizzard and Intel hursday. Here are the metrics that matter moving forward.
Gilead stock has been stagnating, but there are other choices for investors. How about considering Celgene over GILD stock?
From The Street
Everything Jim Cramer said about the stock market on 'Mad Money,' including the week ahead, iPhone sales, AbbVie vs. Bristol-Myers and Zscaler CEO
From Seeking Alpha
Navellier RatingsPowered by Portfolio Grader
10 Stocks Set for Monster Growth
He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!
Download your FREE COPY!